Study uses brain tumor tissue and scans to track treatment outcomes
Part of Brain & nervous system, Cancer clinical trials.
This is an observational study that collects and compares information from patients with primary brain tumors and their treatment results. It uses stored tumor tissue and brain scans to better understand outcomes using updated tumor classification methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult at the age you can legally consent in your country
- You have a primary brain tumor that is newly diagnosed or has come back (recurrent)
- Stored tumor tissue from your first surgery (preferred) or from surgery for recurrence is available at the study site
- You have brain imaging (MRI or CT) from when the tumor was first diagnosed
- You (or, if you are the caregiver for a deceased patient, the legal process allows it) agree to research use of your data and scans
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with glioma who have tumor tissue or blood samples stored. It uses artificial intelligence to analyze these samples and find the best treatment. You might be eligible if you are at least 18 years old and have had a glioma diagnosis with tissue available for study.
This trial studies how brain tumors (like high-risk gliomas, medulloblastoma, and ependymoma) respond to treatment and why they sometimes become resistant. It is for young people aged 15 to 39 and aims to use tumor tissue samples to understand the tumor better and guide future therapies.
This study tests a new way to choose treatment for people with brain tumors that have not responded to standard therapies. Your tumor sample is analyzed in the lab to find which drugs might work best for you, and then you receive a personalized treatment plan.
This study looks at how brain tumors look on MRI and what biopsy tissue shows, using samples taken during planned surgery. It may help improve understanding of tumor biology and future treatment planning.
This trial studies newly diagnosed or progressing brain tumors (grade 2–4 gliomas) to better understand the disease using tumor tissue and blood samples. It may help doctors learn which treatments could work best for different tumor types by matching tumor material to blood results.
This study collects medical information (and sometimes tumor tissue) from people diagnosed with certain brain tumors after January 1, 2012. It aims to improve understanding of these tumors worldwide so future care can be better.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.